Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.

Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab. Acta Derm Venereol. 2017 Sep 13;: Authors: Schuch A, Fischer T, Boehner A, Biedermann T, Volz T PMID: 28902952 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28902952?dopt=Abstract

Source: Acta Dermato-Venereologica - September 13, 2017 Category: Dermatology Authors: Schuch A, Fischer T, Boehner A, Biedermann T, Volz T Tags: Acta Derm Venereol Source Type: research

More News: Dermatology | Hidradenitis